VC
Vivo Capital’s Viridian Therapeutics VRDN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $13.7M | Hold |
982,576
| – | – | 1.41% | 12 |
|
2025
Q1 | $13.2M | Hold |
982,576
| – | – | 1.75% | 9 |
|
2024
Q4 | $18.8M | Sell |
982,576
-695,631
| -41% | -$13.3M | 2.11% | 9 |
|
2024
Q3 | $38.2M | Hold |
1,678,207
| – | – | 3.16% | 9 |
|
2024
Q2 | $21.8M | Hold |
1,678,207
| – | – | 2.02% | 10 |
|
2024
Q1 | $29.4M | Hold |
1,678,207
| – | – | 2.31% | 11 |
|
2023
Q4 | $36.6M | Hold |
1,678,207
| – | – | 2.99% | 9 |
|
2023
Q3 | $25.7M | Hold |
1,678,207
| – | – | 2.82% | 11 |
|
2023
Q2 | $39.9M | Hold |
1,678,207
| – | – | 2.76% | 8 |
|
2023
Q1 | $42.7M | Hold |
1,678,207
| – | – | 2.96% | 6 |
|
2022
Q4 | $49M | Buy |
1,678,207
+18,188
| +1% | +$531K | 5.64% | 3 |
|
2022
Q3 | $34M | Buy |
1,660,019
+360,019
| +28% | +$7.38M | 3.76% | 10 |
|
2022
Q2 | $15M | Hold |
1,300,000
| – | – | 1.51% | 16 |
|
2022
Q1 | $24M | Hold |
1,300,000
| – | – | 1.66% | 12 |
|
2021
Q4 | $25.7M | Hold |
1,300,000
| – | – | 1.55% | 15 |
|
2021
Q3 | $21.4M | Buy |
+1,300,000
| New | +$21.4M | 0.96% | 23 |
|